IM/IV Drug Administration

Administered by: Dr. Emily White, General Practitioner Date: 1 November 2024 Medication Administered: Name: Amoxicillin Dose: 500 mg Route: Intramuscular Site: Left deltoid muscle Batch number: AMX789012 Expiry date: 15 February 2026 Indication for administration: Treatment of acute bacterial sinusitis, unresponsive to oral antibiotics. Duration of therapy required: 7 days Pre-administration assessment: Vital signs: Pulse: 72 bpm, Blood Pressure: 120/80 mmHg, Temperature: 37.1°C, Respiratory Rate: 16 breaths/min Allergies: Patient reports no known drug allergies. Confirmed no contraindications to Amoxicillin. Patient consent: Informed consent obtained, patient understood the purpose and potential side effects of the medication. Other relevant observations: Patient appeared calm and cooperative. No signs of distress or anaphylaxis risk factors noted. Post-administration monitoring and observations: Patient tolerated the injection well. No immediate adverse reactions observed (e.g., rash, swelling, difficulty breathing). Patient remained in clinic for 15 minutes post-administration for observation. Follow-up instructions / advice given: Advised patient to complete the full course of Amoxicillin as prescribed. Counselled on potential side effects (e.g., nausea, diarrhoea) and to seek urgent medical attention if experiencing signs of allergic reaction (e.g., severe rash, swelling of face/throat, difficulty breathing). Follow-up appointment scheduled for 5 November 2024 to assess treatment efficacy.